Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia. Zablonski KG, Skupa SA, Eiken AP, Sundaram S, et al. Leuk Lymphoma 2024 Sep 27:1-9. doi: 10.1080/10428194.2024.2398663.

Read + Share

Amedeo Smart

Independent Medical Education

Zablonski KG, Skupa SA, Eiken AP, Sundaram S, et al. Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia. Leuk Lymphoma 2024 Sep 27:1-9. doi: 10.1080/10428194.2024.2398663.
PMID: 39331474